Professional Documents
Culture Documents
DISCLAIMER This publication was prepared by the Guidance and Support Group of the Canadian Institute of Chartered Accountants (CICA). It has not been approved by any Board of Committee of the CICA or any Provincial Institute/Ordre. The CICA and the authors do not accept any responsibility or liability that might occur directly or indirectly as a consequence of the use, application or reliance on this material. For information regarding permission, please contact permissions@cica.ca
Financial Instruments
TABLE OF CONTENTS
Paragraph Introduction Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Overview of Section 3856 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Scope. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Recognition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Trade date accounting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Classication . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Liability or equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Preferred shares issued in a tax planning arrangement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Examples Liability vs. equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Compound instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Measurement Initial measurement of arms length transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Financing fees and transaction costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Costs related to investment in equity instrument . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Demand loans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Loan fees and costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Loans at non-market interest rates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Off-market loan related to asset purchase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Indexed nancial liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Convertible nancial liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Residual method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Relative fair value method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Initial measurement of convertible liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Initial measurement of related party transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Initial measurement of loan to manager . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Subsequent measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cost/amortized cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Equity instrument measured at cost . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Interest-bearing investment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Amortization of original purchase premium or discount, nancing fees and transaction costs . . . . . . . . . . . . . Example Investment in debt instrument issued at a discount . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Amortization of discount on off-market loan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Amortization of discount on employee interest-free loan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Decision tree Impairment process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Identify assets to assess for impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Indications of impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Measurement of impairment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Present value of future cash ows of a loan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Cash ow estimates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Impairment of groups of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Reversals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Impairment reversal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fair value . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Fair value sources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Calculating the change in fair value of a forward contract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Calculating the change in fair value of an interest rate swap . . . . . . . . . . . . . . . . . . . . . . . . . . . Indexed nancial liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Indexed nancial liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1
1-3 4-5 6-7 8-9 9 10-23 12-23 20 21 22-23 24-30 25-26 26 27-29 29 30-31 31 32 33-37 35 36 37 38-39 39 40-76 40 41-68 42 43 44 45 46 47 48-68 49 50 55 56-64 60 64 65 66-68 68 69-73 71 72 73 74-76 76
Financial Instruments
Presentation Offsetting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Interest, dividends, gains, losses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Derecognition. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Financial assets Securitization transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Illustration Typical securitization transaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Measurement of interest held after a transfer of receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Recording transfers with proceeds of cash, derivatives, and other liabilities . . . . . . . . . . . . . . . Example Recording transfers of partial interests . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Servicing assets and liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Recognizing a servicing liability in a transfer of receivables . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Sale of receivables with servicing retained . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Recording transfers of partial interests with proceeds of cash, derivatives, other liabilities, and servicing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Fair value Example Recording transfers if it is not practicable to estimate a fair value . . . . . . . . . . . . . . . . . . . . . . . Sales-type and direct nancing lease receivables Example Recording transfers of lease nancing receivables with residual values. . . . . . . . . . . . . . . . . . . Financial liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Investment banker acting as agent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Modication of line of credit or other revolving debt arrangement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Determining whether borrowing capacity exceeds that of the old arrangement and related accounting implications of fees and costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Extinguishing nancial liabilities with equity instruments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Convertible liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Accounting on extinguishment of compound nancial instrument . . . . . . . . . . . . . . . . . . . . . . . Hedge accounting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hedged item . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hedging item . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Commodity hedge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Hedge of anticipated purchase of a commodity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Currency hedge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Foreign currency hedge of anticipated purchase of a commodity . . . . . . . . . . . . . . . . . . . . . . . . Example Hedge of anticipated foreign currency transaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hedge of interest rate risk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Interest rate swap . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cross-currency interest rate swap . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example - Cross-currency interest rate swap . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hedge of the net investment in a self-sustaining foreign operation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Mechanics of hedge accounting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Example Effect of hedge accounting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Examples Hedge of foreign currency anticipated transaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Additional examples Hedge of foreign currency anticipated transaction . . . . . . . . . . . . . . . . . . . . . . . . . . Example Hedge of interest rate risk with interest rate swap . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Appendix Denitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
77-83 84-85 86-119 87-102 91 93-94 93 94 95-100 97 98 100 101 102 103-119 112 113-114 114 115-117 118-119 119 120-147 120-125 126-128 129 130-131 131 132-136 133 136 137-140 138 139-140 140 141 142-147 144 145 146 147 148-159 A1
Financial Instruments
INTRODUCTION This publication has been produced in response to requests for guidance on the application of Section 3856, Financial Instruments, in the CICA Handbook Accounting, Part II, Accounting Standards for Private Enterprises. The CICA expresses its appreciation to the principal author of the publication, Jo-Ann Lempert, CA, and to Kate Ward, CA, for her technical review. The guidance and illustrative examples provided are not authoritative. All decisions on the application of any accounting standard need to be made based on a thorough understanding of the facts and circumstances of each transaction and through the application of professional judgment. The guidance in this publication is current as of the date of publication. Judgment will need to be applied as practice evolves or Section 3856 is updated.
Financial Instruments
BACKGROUND 1. The nancial instrument standards previously contained in Part V of the CICA Handbook were highly criticized for being complex and often requiring resources that are beyond those cost-effectively available to many private enterprises. In some situations, these standards required the use of fair value measurements for nancial instruments that sometimes involved sophisticated nancial modelling and access to a variety of market price sources that many private companies did not have. Also, private companies struggled with determining impairment losses on nancial instruments due to multiple models existing in previous standards. Lastly, the hedge accounting model, designed mainly for publicly accountable enterprises, increased the number of fair value measurements and imposed extensive documentation and analytical requirements which private companies found to be very complex and onerous. In response to these criticisms, the Canadian Accounting Standards Board (AcSB) decided to start afresh and so developed the new CICA Handbook section, FINANCIAL INSTRUMENTS, Section 3856. This Standard simplies the accounting for nancial instruments by providing a single accounting standard that applies to all nancial assets and nancial liabilities. Section 3856 replaced several standards previously found in Part V of the CICA Handbook Accounting including TEMPORARY INVESTMENTS, Section 3010; ACCOUNTS AND NOTES RECEIVABLE, Section 3020; IMPAIRED LOANS, Section 3025; LONG-TERM DEBT, Section 3210; FINANCIAL INSTRUMENTS RECOGNITION AND MEASUREMENT, Section 3855; FINANCIAL INSTRUMENTS DISCLOSURE AND PRESENTATION, Section 3860; FINANCIAL INSTRUMENTS DISCLOSURE AND PRESENTATION, Section 3861; FINANCIAL INSTRUMENTS DISCLOSURES, Section 3862; FINANCIAL INSTRUMENTS PRESENTATION, Section 3863; and HEDGES, Section 3865. In developing the new Standard, the AcSB maintained that the previously existing principles should continue to apply. However, in order to ensure that the costs of applying these principles would not exceed the benets of applying them, the AcSB modied the application of these principles. The underlying principles guiding Section 3856 are as follows: (a) Financial Instruments represent rights or obligations that meet the denitions of assets or liabilities and should be reported in nancial statements. (b) Fair value is the most relevant measure for nancial instruments and the only relevant measure for derivative instruments. (c) Only items that are assets or liabilities should be reported as such in nancial statements. (d) Special accounting for items designated as being hedged should be provided only for qualifying items. OVERVIEW OF SECTION 3856 4. Section 3856 provides guidance on the accounting treatment of nancial instruments. It answers the following questions: (a) What is a nancial instrument? (i) The Standard lists several examples of common nancial instruments. It also describes transactions that resemble or may be nancial instruments but that are not dealt with in the Scope of the Standard (paragraph 6 of this chapter). The Standard requires that nancial instruments be recognized when an entity becomes a party to a contract involving nancial instruments, i.e., immediately (paragraph 8). The Standard requires that a nancial instrument be initially measured at its fair value plus, when it will be subsequently measured at cost or amortized cost, any related transaction costs and nancing fees (paragraphs 24-25).
2.
3.
(b) When should a nancial instrument be recognized in the nancial statements? (i)
(c) How should a nancial instrument be measured when it is initially recognized and thereafter? (i)
(ii) For subsequent measurement, the Standard requires the nancial instrument to be classied into one of the two following categories: Fair value (paragraphs 10 and 40) Cost/Amortized cost (paragraphs 40-41).
The classication decision will be primarily based on the instruments characteristics but the entity may elect to classify an instrument to the fair value category on initial recognition. (iii) All nancial instruments classied into the cost/amortized cost category, must be assessed for impairment at the end of each reporting period (paragraph 48). (d) How should a nancial instrument be presented? (i) The Standard provides guidance on classifying a nancial instrument, or its component parts, as a liability or part of equity based on the substance of the arrangement (paragraph 12).
4
Financial Instruments
(ii) The equity component of a nancial liability that is convertible to equity must be recognized separately. Section 3856 permits measuring the equity component as zero. If this measurement option is not chosen, the equity component may be measured using any rational method including the residual method and the relative fair value method (paragraph 33). (iii) Section 3856 requires that preferred shares issued in a tax planning arrangement under specied sections of the Canadian Income Tax Act be presented at par, stated or assigned value as a separate line item in the equity section of the balance sheet, with a description indicating that they are redeemable at the option of the holder (paragraph 20). (iv) A nancial asset may be offset with a nancial liability only when both of the following criteria are met: (i) The entity currently has a legally enforceable right of offset; and The entity intends to settle on a net basis, or, to realize the items simultaneously (paragraph 80).
(e) When is a nancial instrument derecognized? For transferred receivables, only when control has been surrendered (paragraph 86); (ii) For a nancial liability, when it is extinguished (paragraph 103). (f) When and how can hedge accounting be applied (paragraph 120)? (i) Hedge accounting is optional. (ii) Hedging is only permitted in specic circumstances. (iii) Hedge accounting will only be allowed when the critical terms of the hedging item and hedged item match. (iv) Specic details of the hedging relationship must be documented. (v) When hedge accounting is achieved, accounting for the hedging item is modied. (vi) Hedge accounting cannot be electively discontinued, but is discontinued when the critical terms of the hedged item and the hedging item no longer match. (g) What is required to be disclosed regarding nancial instruments? (i) In general, information that enables users to evaluate the signicance of nancial instruments on the nancial position and performance of an entity must be disclosed (paragraph 148).
Financial Instruments
5.
The following chart illustrates the application of Section 3856 to nancial instrument transactions. General application of Section 3856, Financial Instruments
Has the entity become a party to the contractual provisions of a nancial instrument? Yes Is the nancial instrument excluded from the scope of Section 3856 as set out in paragraph 3856.03? No Is the transaction with a related party? Yes Is the relationship solely in the capacity of management (paragraph 3856.09)? Yes No The transaction is measured in accordance with RELATED PARTY TRANSACTIONS, Section 3840 Yes Other standards may apply Not sure Go to paragraph 6 of this chapter
No
Will the instrument be measured at fair value or amortized cost subsequent to initial recognition?
Fair value Investments in quoted equity instruments Derivative contracts other than those linked to another private entity and those in qualifying hedging relationships Other nancial instruments if fair value measurement is elected at initial recognition (election is irrevocable)
Cost or amortized cost Investments in unquoted equity instruments Derivatives that are not measured at fair value All other nancial assets and nancial liabilities not measured at fair value
Initial measurement
Measure initially at fair value Transaction costs are expensed in the period incurred Measure initially at fair value plus or minus transaction costs and nancing fees, if applicable
Subsequent measurement
Fair value Financial assets and liabilities other than hedging instruments or indexed liabilities Hedging instruments Indexed nancial liabilities
Amortize any initial premium or discount and any transaction costs or nancing fees to net income over the expected life of the instrument
Derivative hedging instruments are recognized at the earlier of: Date a payment is received or made; and Date the hedged instrument is recognized (i.e., hedging instrument receipt or payment is accrued)
At each reporting date measure at the higher of: the amortized cost of the debt; and the amount that would be payable if the indexing formula was applied on the reporting date The adjustment for changes in value due to the indexing feature, if any, is recognized immediately in net income as a separate component of interest expense
Assess all nancial assets for indications of impairment at each reporting date
Record the asset at the highest of: Is there a signicant change in the expected timing or amount of future cash ows? PV of cash ows expected from holding the asset Selling price at balance sheet date Expected net proceeds from liquidating collateral held
If previously impaired, assess for reversal of condition causing impairment in earlier period
Financial Instruments
SCOPE 6. What is a nancial instrument? Denitions of nancial asset and nancial liability are in paragraph 3856.05: Examples of items that are not accounted for in the scope of Section 3856 The cost incurred by an entity to purchase a right to reacquire its own equity instruments from another party; this is a deduction from equity (paragraph 3856.05(h)) Prepaid expenses Inventories Property, plant and equipment Leased rights and assets (paragraph 3856.03(b)) Intangible assets such as patents and trademarks Income taxes Investments in subsidiaries, variable interest entities, entities subject to signicant inuence or joint ventures (paragraph 3856.03(a)*
Examples of nancial instruments cash demand and xed-term deposits commercial paper bankers acceptances treasury notes and bills
a contractual right to receive cash or another nancial asset from another party a contractual right to exchange nancial instruments with another party under conditions that are potentially favourable
accounts, notes and loans receivable bonds and similar debt instruments held as investments common and preferred shares and similar equity instruments held as investments options, warrants, futures contracts, forward contracts, and swaps (these items also meet the denition of a derivative see below) (paragraph 3856.02) accounts, notes and loans payable (3856.02(d)) bonds and similar debt instruments issued (paragraph 3856.02(e)) perpetual debt instruments preferred shares, shares in co-operative organizations and interests in partnerships, and similar equity instruments issued (paragraph 3856.02(f))
A nancial liability is any liability that is a contractual obligation: to deliver cash or another nancial asset to another party; or to exchange nancial instruments with another party under conditions that are potentially unfavour- able to the entity
* 7.
options, warrants, futures contracts, forward contracts, and swaps (these items also meet the denition of a derivative see below) (paragraph 3856.02(g)) See Sections 3051, 3055, 1590 and AcG-15 as appropriate.
Section 3856 applies to items that are created by contracts so payables and receivables that result from statutory requirements, such as income or excise taxes, are not in the scope. RECOGNITION
8.
Financial instruments are initially recognized in nancial statements when the entity becomes a party to the contractual provisions of the nancial instruments. This will normally happen when an entity commits to purchase or sell a nancial instrument (otherwise referred to as the trade date). This approach accurately reects the economic effects of transactions and is the only recognition date that provides transparency for derivatives.
Financial Instruments
9.
Example Trade date accounting On December 30, 20X1, Buy Co. purchases 100 shares of a company for its fair value of an aggregate amount of $100. The transaction settles on January 2, 20X2 at which time, Buy Co. receives and pays for the shares. On December 31, 20X the fair value of the shares has increased to $115 in aggregate, and by the time the transaction settles on January 2, 20X2 the fair value of the shares has increased to $125. Journal Entries Subsequent measurement at amortized cost Subsequent measurement at fair value (i.e., investment in private company shares) (i.e., investment in public company shares) December 30, 20X1 Dr. Investment in shares $100 Dr. Investment in shares $100 Cr. Payable $100 Cr. Payable $100 December 31, 20X1 No Entry Dr. Investment in shares $15 Cr. Unrealised fair value increase* $15 January 2, 20X2 Dr. Payable $100 Dr. Investment in shares $10 Cr. Cash $100 Dr. Payable 100 Cr. Unrealised fair value increase* $ 10 Cr. Cash 100 * This description is not a required title, it is used simply to describe the change in fair value that is recognized in net income.
CLASSIFICATION 10. Section 3856 requires few classication decisions. Freestanding derivatives (other than those in qualifying hedging relationships and those that are linked to and settle with delivery of the equity instruments whose fair value cannot be readily determined) and investments in equities that are quoted in an active market must be measured at fair value subsequent to their initial recognition (paragraph 3856.12). On initial recognition, any nancial asset or nancial liability may be designated as measured at fair value. Also, fair value measurement may be elected for an equity instrument that ceases to be quoted in an active market. Fair value measurement may be useful when the asset or liability will be hedged with a derivative but hedge accounting would or could not be applied. These elective applications of fair value measurement are irrevocable (paragraph 3856.13). It might make sense to use the irrevocable election to measure nancial instruments at fair value in the following situations: (a) When investments that are eligible for amortized cost measurement are managed on a fair value basis. For example, when surplus cash is invested in a portfolio containing both interest-bearing and equity securities, it is often easier to assess the performance of the portfolio when all of the securities are measured on the same basis. (b) Accounting for all investments on a fair value basis may simplify bookkeeping. Maintaining amortization schedules for interest-bearing items is operationally more challenging than recording fair values and cash transactions. (c) When it is unclear whether the nancial instrument is traded in an active market. It is important to understand the nature of the investment. For example, some mutual fund units are not redeemable daily so are not considered actively traded. However, it is usually easier and more useful to measure these investments at fair value. (d) When fair value is more relevant for the users. (e) To simplify the accounting for transaction costs. Transaction costs must be amortized over the life of any nancial instrument measured at amortized cost. Liability or equity 12. Guidance on the classication of an issued nancing instrument between a nancial liability and an equity instrument is included under the heading Presentation in paragraphs 3856.20-.23.
11.
Financial Instruments
13.
In some cases, it may be difcult to determine whether a nancial instrument should be considered a liability or equity. For example, some nancial instruments take the legal form of equity but are liabilities in substance because they require payment to the holder of a xed or determinable amount. Others may combine features associated with equity instruments and features associated with nancial liabilities, therefore making it difcult to distinguish whether it is an equity or liability instrument in its entirety.
14. In distinguishing whether a nancial instrument should be classied as a liability or equity instrument, the denitions of these instruments should be considered as follows: Paragraph 3856.05(e) An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Paragraph 3856.05(j) A nancial liability is any liability that is a contractual obligation: (i) to deliver cash or another nancial asset to another party; or (ii) to exchange nancial instruments with another party under conditions that are potentially unfavourable to the entity. 15. The substance of the contractual terms of a nancial instrument, rather than its legal form, governs its classication on the issuers balance sheet. This determination is made on initial recognition of the instrument, disregarding any non-substantive or minimal features, and this classication is not revised unless the terms of the instrument change or it is removed from the balance sheet. When considering whether the nancial instrument, or its component parts, meets the denition of a nancial liability, the existence of a restriction on the ability of the issuer to satisfy an obligation, such as lack of access to foreign currency or the need to obtain approval for payment from a regulatory authority, does not negate the issuers obligation or the holders rights under the instrument. When an issuer has a contractual obligation to deliver a xed amount or an amount that varies either partially or fully in response to changes in a variable, other than the market price of the entitys own equity instruments, and the issuer is required to or is able to settle the contractual obligation by delivering enough of its own equity instruments to satisfy the obligation, this would be considered a nancial liability because the counterparty is guaranteed a xed value and is not subject to the residual risk of the issuer. When an issuer does not have a contractual obligation to deliver cash or another nancial asset or to exchange another nancial instrument under conditions that are potentially unfavourable, the instrument is equity. When the issuer is not contractually obligated to distribute a pro rata share of any dividends or other distributions out of equity, even when the holder may be entitled to such distributions, it is considered an equity instrument. The classication of a nancial instrument between liability and equity is not changed based on a change in estimate of the probability of a future event occurring. If the future event passes, and the nancial instrument still exists, it is derecognized, and a new nancial liability or equity instrument is recognized based on the remaining terms. Similarly, the classication would not be impacted by historical experience or intentions but would be based on the actual substance of the contractual arrangements themselves.
Preferred shares issued in a tax planning arrangement
16.
17.
18.
19.
20.
The only exception to the above guidance applies to preferred shares issued in a tax planning arrangement under Sections 51, 85, 85.1, 86, 87 or 88 of the Canadian Income Tax Act that are redeemable at the option of the holder. These shares should be presented at par, stated or assigned value as a separate line item in the equity section of the balance sheet, with a suitable description indicating that they are redeemable at the option of the holder. When redemption is demanded, the shares are reclassied as liabilities and measured at the redemption amount. Any adjustment is recognized in retained earnings.
Financial Instruments
21.
Examples Instruments that would be considered a nancial liability vs. an equity instrument Financial liability An entity receives $10,000 and promises to deliver the $10,000 or shares equal in value to $10,000 in 3 years time. An entity receives $10,000 and promises to deliver shares in 3 years time equal to the value of gold at that time. Preferred shares* issued in the amount of $10,000 to be redeemed at a xed date (as per the contractual arrangement) for a xed price and paying mandatory scheduled dividends. Preferred shares* issued in the amount of $10,000 to be redeemed at a xed date for a xed price without mandatory dividend payment, when declared. A retractable or mandatorily redeemable share that does not meet the criteria to be classied as an equity instrument. Equity instrument An entity receives $10,000 and promises to deliver 10,000 shares in 3 years time. An entity receives $10,000 and promises to deliver a xed number of shares at a xed date. Preferred shares* issued in the amount of $10,000 with no specied repayment date, redeemable at the option of the issuer, with no stipulated dividend payments, when declared. Preferred shares* issued in the amount of $10,000 with no specied repayment date, redeemable at the option of the issuer, paying mandatory scheduled dividends. A retractable or mandatorily redeemable share that: Is the most subordinated of all equity instruments issued by the entity and participates on a pro rata basis in the residual equity; The redemption feature is extended to 100% of the common shares (and/or in-substance common shares), and the basis for determination of the redemption price is the same for all shares; All of the redeemable shares include substantially similar characteristics to the enterprises common shares; for example, they do not include any substantive liquidation preferences or dividend distribution preferences.
The redemption event is the same for all the shares subject to the redemption feature, for example, redemption on the resignation, termination, retirement or death of the shareholder. These shares are not subject to the exception above, i.e., they are not issued in a tax planning arrangement under Sections 51, 85, 85.1, 86, 87 or 88 of the Canadian Income Tax Act.
Compound nancial instruments 22. When a nancial instrument contains both liability and equity elements, each element should be classied in accordance with its substance, taking into consideration the denitions of a nancial liability and equity instrument. A nancial position is more faithfully represented by separate presentation of the liability and equity components contained in a single instrument according to their nature. For example, when a nancial liability includes detachable warrants or options, it is more a matter of form than substance that both liabilities and equity interests are created by a single nancial instrument rather than two or more separate instruments. The separate classication based on the substance of the contractual terms of the arrangement discussed above would still apply when a nancial instrument contains components that are neither nancial liabilities nor equity instruments of the issuer. For example, an instrument that gives the holder the right to receive a non-nancial asset such as an amount of gold (i.e., a commodity) on settlement and an option to exchange that right for shares of the issuer contains both liability and equity elements. The issuer recognizes and presents the equity instrument (the exchange option) separately from the liability components of the compound instrument, whether the liabilities are nancial or non-nancial. MEASUREMENT Initial Measurement Arms length transactions 24. Financial instruments issued or acquired in arms length transactions are measured initially at fair value. Given that fair value is the price that an arms length market participant would pay or receive in a routine transaction under the market conditions at the time of initial recognition, a nancial instruments initial fair value will normally be the transaction price, that is, the fair value of the consideration given or received.
23.
10
Financial Instruments
Financing Fees & Transaction Costs
25.
The treatment of any nancing fees and transaction costs directly attributable to the origination, acquisition, issuance or assumption of nancial instruments depends on the subsequent measurement of the instrument. When the instrument will be measured at fair value, transaction costs and nancing fees are recorded in income in the period incurred because they are not part of the fair value of the nancial instrument and they do not meet the denition of an asset necessary for separate recognition (paragraph 3856.12). When the instrument will be measured at cost or amortized cost, nancing fees and transaction costs are included in the initial measurement of the instrument. Transaction costs included in the initial measurement of an interest-bearing instrument are amortized over the life of the instrument (paragraphs 3856.07 and .A3). Standby fees and transaction costs associated with a line of credit or revolving debt arrangement are recognized as a prepaid expense and amortized over the life of the commitment because they are, in substance, analogous to an insurance premium. The fee is the cost associated with having the ability to draw down the loan over the term of the arrangement (paragraph 3856.A57). Example Investment in equity instruments at cost On February 14, 20X1, Investor Corporation invests $10,000 in 10,000 common shares of Private Corporation, giving Investor Corp. a 10% voting interest in the company. Investor Corp. and Private Corp. are unrelated, and the price paid for the acquisition of the common shares represented fair value of the shares at the purchase date. Investor Corp. also incurred $500 in legal fees to register the title of the shares in their name. Date Entry February 14, 20X1 Dr. Investment in Private Corporation $10,500 Cr. Cash $10,500
Demand Loans
26.
27.
The fair value of a nancial liability with a demand feature is not less than the amount payable on demand, discounted from the rst date that the amount could be required to be paid. The maturity date of an item with no contractual repayment terms cannot be later than the earliest date on which payment can be demanded. The initial fair value for such nancial liabilities is usually the price at which they are originated between the customer and the lender, that is, the demand amount. However, the effect of discounting would need to be considered in a high interest rate environment for a loan payable on 30 days notice (paragraph 3856.A12). The interest rate used to discount a nancial instrument payable on demand should be the rate available to the entity on a similar nancial instrument maturing on, or as close as possible to, the rst date that the instrument could be required to be paid. It incorporates any risk premium that a third party would charge for a nancial instrument of comparable credit quality and terms (paragraph 3856.A13).
28.
11
Financial Instruments
29.
Examples Accounting for demand loans and revolving debt fees and costs Example 1 Term loan Bank of Lenders agrees to lend Borrowing Corporation $100,000 for 5 years, bearing annual interest at 6%, payable monthly, with principal repayable in full at maturity. Bank of Lenders is able to demand repayment of the loan at anytime if specied conditions are not met. On issuance of the loan, Bank of Lenders charges Borrowing Corporation transaction costs in the amount of $1,250 to write the loan and register collateral on it. Dr. Cash $98,750 Cr. Loan payable Example 2 Demand loan with no terms of repayment Borrowing Corporation arranges a demand loan with Bank of Lenders in the amount of $100,000. Bank of Lenders is able to demand repayment of the loan at anytime. The loan carries an annual interest rate of 6%. On issuance of the loan, the bank charges Borrowing Corporation a $1,250 origination fee. Example 3 Revolving line of credit Borrowing Corporation arranges with Bank of Lenders to enter into a revolving line of credit with a limit of $100,000. Bank of Lenders is able to demand repayment of the line at anytime. The line carries an annual interest rate of 6%. On issuance of the line, the bank charges Borrowing Corporation a $1,250 annual standby fee.
Dr. Cash
$98,750
Cr. Loan payable $98,750 End of year 1 entry Dr. Interest Dr. Interest expense* $250 expense* $1,250 Cr. Loan Cr. Loan payable $250 payable $1,250 This example uses the straight-line * This account can also be called amortization method but the effective Amortization of Loan Fee or someinterest method can alternatively be thing similar and can be presented as a used. separate component of interest expense * This account can be presented as a in the income statement. separate component of interest expense in the income statement: Interest on bank loan $6,000 $98,750 Amortization of loan fee Total interest expense
Loans at non-market interest rates
$1,250 $1,250
Dr. Interest expense* $1,250 Cr. Prepaid expenses $1,250 * This account can also be as called Amortization of Prepaid Fee or something similar and can be presented as a separate component of interest expense in the income statement.
250 $6,250
30.
A loan with an interest rate that is signicantly less than a market rate of interest indicates that there is more to the transaction than a pure lending/borrowing relationship. The present value of the difference between the rate on the loan and a fair market lending rate may represent part of the price of an asset nanced by the loan, a government grant to incent the borrower to undertake certain commercial transactions, or compensation to an employee (see paragraph 47 below). Example - Loan with a non-market rate of interest related to asset purchase On February 14, 20X1, Seller Corporation nances Customer Co.s purchase of a $1,000 machine by extending payment for 3 years. Interest is payable annually at 3%. The market rate of interest for a similar loan to an entity with Customers credit rating is 5%. The loan is initially measured at its fair value of $946 (net present value of $30 of interest for 3 years and principal repayment of $1,000 discounted at 5%). The transaction is accounted for as follows: Date Sellers books Customers books February 14, 20X1 Dr. Loan receivable $946 Dr. Machine $946 Cr. Revenue $946 Cr. Loan payable $946
31.
12
Financial Instruments
Indexed Financial Liabilities
32.
Private enterprises often issue debt that requires payments to be determined by reference to factors such as the value of the enterprises equity or performance measures such as earnings before interest, taxes, depreciation and amortization. These instruments are initially measured at fair value, usually the proceeds of the issue, unless they are related party transactions that are outside the scope of Section 3856.
Convertible Financial Liabilities
33.
Private enterprises also often issue debt that includes an option for the holder to acquire equity of the issuer under specied circumstances (compound instrument). These options are similar in nature to options or warrants that are issued with the liability but detachable thereafter. The equity component may be measured as zero or based on fair value measurements as explained below. It is especially important to disclose the terms of the instrument when the zero measurement alternative is chosen to ensure that readers of the nancial statements are aware of the terms of the conversion option. Acceptable methods for initially measuring the separate liability and equity elements of an instrument include the following: (a) The equity component is measured as zero; the entire proceeds of the issue are allocated to the liability component. (b) Residual method the more easily measurable component is measured rst, and the residual amount is allocated to the remaining component. (c) Relative fair value method the total proceeds of the instrument is allocated to the components in proportion to their relative fair values. The sum of the carrying amounts assigned to all the components in an arrangement on initial recognition is always equal to the carrying amount of the instrument as a whole. No gain or loss is realized from recognizing and presenting the components of the instrument separately.
Residual value method
34.
35.
Using the residual method, the more easily measurable component is measured rst, and the residual amount (after deducting from the entire proceeds of the issue the amount separately determined for the component that is more easily measurable) is allocated to the less easily measurable component. Note that IFRSs require use of the residual value method but the equity portion must be calculated as the residual after deducting the fair value of the liability from the proceeds of the issue.
Relative fair value method
36.
When the issuer can reliably estimate the fair value of each of the liability and equity components, the proceeds may be allocated proportionately. This method is used infrequently because of the difculty of establishing fair value measurements for private enterprises.
13
Financial Instruments
37.
Example Initial measurement of convertible liability Capital Corporation (Capital) needs to raise $10,000 to fund its operations and is having difculty nding nancing. It issues bonds in the aggregate amount of $10,000 repayable in 5 years and with an annual interest rate of 6%. The bonds are convertible on a one-for-one basis into common shares of the Corporation in the event of default of the bonds terms. The conversion feature was measured using the Black-Scholes Model at $250 on initial issuance of the bond. Conversion feature is measured at zero Dr. Cash $10,000 Cr. Liability $10,000 Cr. Conversion feature (equity) 0 Conversion feature is measured at fair value residual method Dr. Cash $10,000 Cr. Liability $9,750 Cr. Conversion feature (equity) 250 Liability and conversion feature are measured pro rata relative fair value method Dr. Cash $10,000 Cr. Liability $9,754 Cr. Conversion feature (equity) 246 From Capitals perspective, the bond comprises two components: a nancial liability (a contractual arrangement to deliver cash or other nancial assets) and an equity instrument (a conversion option granting the holder the right, for a specied period of time and upon satisfaction of certain conditions, to convert into common shares of Capital). Capital presents the liability and equity components separately on its balance sheet when the equity component is allocated a value. See paragraph 155 below for examples of the disclosures required for convertible liabilities. Initial Measurement Related party transactions
38.
Related party transactions are measured in accordance with RELATED PARTY TRANSACTIONS, Section 3840 except for those that involve parties whose sole relationship with an entity is in the capacity of management. Management is dened in paragraph 3840.04(d) as follows: Paragraph 3840.04(d) Management: any person(s) having authority and responsibility for planning, directing and controlling the activities of the reporting enterprise. (In the case of a company, management includes the directors, ofcers and other persons fullling a senior management function. When an independent committee of the board of directors is established in accordance with regulatory requirements, to represent the non-controlling interests of an enterprise, the directors serving on that committee are deemed not to be related parties for the transaction under consideration.)
39.
Example Non-interest bearing loan to manager Mr. Manager receives a non-interest-bearing, ve-year housing loan in the amount of $25,000 on January 1, 20X1 from his employer, Bonus Corporation. The loan is due in full on January 1, 20X6. Because Mr. Managers only association with the Company is in his capacity as a manager, i.e., he does not own shares of Bonus Corporation, Bonus would have to measure this transaction on January 1, 20X1 at its fair value in accordance with Section 3856.07. Assuming the prevailing market interest rate for a similar loan for ve years with a similar credit rating were 5%, Bonus Corporation would record the following entry on initial recognition of the loan: Dr. Loan receivable $19,588.15 Dr. Compensation expense 5,411.85 Cr. Cash $25,000.00
14
Financial Instruments
Subsequent measurement
Overview
40.
Most measurements in Section 3856 can be applied on an instrument-by-instrument basis, i.e., most are not policy choices. The following chart summarizes the subsequent measurement requirements. Cost/Amortized cost (paragraph 41 below) Measurement at cost/amortized cost (when not designated at fair value) Investments in equity instruments not quoted in an active market Derivatives designated in a qualifying hedging relationship Derivatives that are linked to, and must be settled by delivery of, equity instruments of another entity whose fair value cannot be readily determined All other nancial assets not measured at fair value Financial liabilities Fair value (paragraph 69 below) Mandatory fair value measurement Optional fair value measurement Investments in equity instruments quoted in an active Any nancial asset or nancial liability designated on market initial recognition Derivatives not designated in a qualifying hedging relationship Equity instruments that cease to be quoted in an active market
Derivatives that are linked to, and must be settled by delivery of, equity instruments of another entity whose fair value can be readily determined Indexed nancial liabilities (paragraph 74 below) At each reporting date, indexed nancial liabilities are measured at the higher of: the amortized cost of the debt; and the amount that would be payable if the indexing formula was applied at that date. Adjustments for changes in the value of the embedded feature are recognized immediately in net income as a separate component of interest expense.
Cost/Amortized cost
41.
Amortized cost is dened in paragraph 3856.05(a) as follows: Paragraph 3856.05(a) Amortized cost is the amount at which a nancial asset or nancial liability is measured at initial recognition minus principal repayments, plus or minus the cumulative amortization of any difference between that initial amount and the maturity amount, and minus any reduction (directly or through the use of an allowance account) for impairment (see paragraphs 3856.A3-.A6). The term cost is not specically dened in Section 3856. A laymans denition describes cost as the amount paid to acquire the nancial instrument.
42.
Example Investment in equity instruments at cost (continued from paragraph 26 below) On December 31, 20X1, Investor Corp.s year-end, the fair value of this investment has increased to $12,500. Investor Corp. would record the following entries throughout the 2011 year related to this investment: Date Entry December 31, 20X1 No entry because the investment is classied by Investor Corp. to be measured at cost, no adjustment is required for the change in fair value.
15
Financial Instruments
43.
Example Investment in Guaranteed Investment Certicates (GICs) On February 14, 20X1, Investor Corporation decides to invest $10,000 in a 30-month Bank of Canadiana non-redeemable GIC which guarantees a return of 2.40%. Investor Corp. did not pay any fees or transaction costs associated with this investment. At December 31, 20X1, the interest rates on similar GICs have decreased to 2.05%, thereby increasing the fair value of this investment by year-end. Investor Corp. would record the following entries throughout the 20X1 year related to this investment: Date Entry February 14, 20X1 Dr. Investment in GIC $10,000 Cr. Cash $10,000 December 31, 20X1 Dr. Interest receivable $ 210 Cr. Interest income $ 210 The increase in fair value of the investment is ignored because the investment is measured at amortized cost.
Amortization of initial purchase premium or discount, nancing fees and transaction costs
44.
Any systematic amortization of premiums/discounts, fees and/or costs to net income may be used. The effective interest method is theoretically preferred but Section 3856 permits use of alternative methods such as the straight-line method. In many situations, the difference between the effective interest method and straight-line amortization will not be material. Example Investment in Government of Canada Treasury Bill On January 1, 20X1, Investor Corporation decides to invest in a one-year $10,000 GOC treasury bill to yield 1.45%: Principal amount of T-bill $10,000 Initial investment ($10,000 discounted at 1.45%) $ 9,857 Interest income recognized over the year $ 143 For interim reporting purposes, the interest may be recognized using any systematic and rational method including straightline amortization (approximately $12 per month).
45.
46.
Example Loan at non-market rate of interest (continued from paragraph 31 above) The net amount of the loan of $946 accretes to $1,000 over its three-year term. The accretion can be determined using any systematic method, including the effective interest method at 5%, or the straight-line method, and can either be shown in net income as part of interest income (Sellers perspective, interest expense for Customer) or on a separate line within interest income/expense. Sellers entries are as follows: Date Effective interest method Straight-line amortization December 31, 20X1 Dr. Loan receivable $41 Dr. Loan receivable $42 Cr. Interest income $41 Cr. Interest income $42 February 14, 20X2 Dr. Cash $30 Dr. Cash $30 Cr. Loan receivable $24 Cr. Loan receivable $24 Cr. Interest income 6 Cr. Interest income 6 December 31, 20X2 Dr. Loan receivable $42 Dr. Loan receivable $42 Cr. Interest income $42 Cr. Interest income $42 February 14, 20X3 Dr. Cash $30 Dr. Cash $30 Cr. Loan receivable $24 Cr. Loan receivable $24 Cr. Interest income 6 Cr. Interest income 6 December 31, 20X3 Dr. Loan receivable $43 Dr. Loan receivable $42 Cr. Interest expense $43 Cr. Interest income $42 February 14, 20X4 Dr. Cash $1,030 Dr. Cash $1,030 Cr. Loan receivable $1,024 Cr. Loan receivable $1,024 Cr. Interest expense 6 Cr. Interest expense 6 (Customers entries would mirror those of Sellers.)
16
Financial Instruments
47.
Example Interest-free loan to manager (continued from paragraph 39 above) Entries to be made over the term of the loan are as follows. Both the straight-line amortization method and the effective interest method are illustrated: Straight-line Amortization Method Effective Interest Amortization Method January 1, 20X1 Dr. Loan receivable $19,588.15 Dr. Compensation expense 5,411.85 Cr. Cash $25,000.00 December 31, 20X1 Dr. Loan receivable $1,082.37 Dr. Loan receivable $979.41 Cr. Interest income $1,082.37 Cr. Interest income $979.41 December 31, 20X2 Dr. Loan receivable $1,082.37 Dr. Loan receivable $1,028.38 Cr. Interest income $1,082.37 Cr. Interest income $1,028.38 December 31, 20X3 Dr. Loan receivable $1,082.37 Dr. Loan receivable $1,079.80 Cr. Interest income $1,082.37 Cr. Interest income $1,079.80 December 31, 20X4 Dr. Loan receivable $1,082.37 Dr. Loan receivable $1,133.79 Cr. Interest income $1,082.37 Cr. Interest income $1,133.79 December 31, 20X5 Dr. Loan receivable $1,082.37 Dr. Loan receivable $1,190.48 Cr. Interest income $1,082.37 Cr. Interest income $1,190.48 January 1, 20X6 Dr. Cash $25,000.00 Dr. Cash $25,000.00 Cr. Loan receivable $25,000.00 Cr. Loan receivable $25,000.00
Impairment
48.
The carrying amount of any nancial asset measured at cost or amortized cost must be reduced if there is a decline in value that is specic to the issuer of the instrument. A decline in value of a stock or group of stocks generally does not give rise to an impairment loss if it relates to an overall decline in equity markets. Similarly, a decline in the value of interest-bearing nancial instruments that related to an increase in interest rates does not create an impairment loss. Section 3856 species one impairment model applicable to all nancial assets measured at cost or amortized cost. This model requires the impairment loss to be determined on the basis of the difference between the current carrying amount of the asset and the cash ows the enterprise could expect to receive in the most favourable outcome. The reduction may be recognized directly or through the use of an allowance account with the offset recognized directly in net income. Losses recognized in previous periods may be reversed if the circumstances related to the original write-down improve.
17
Financial Instruments
49.
Decision tree Process for assessing impairment Step 1: Identify assets to be assessed for impairment Investments in private equity instruments measured at cost Investments in interest-bearing instruments measured at amortized cost that are individually signicant, e.g., bonds, loans, etc. Financial assets measured at amortized cost that share similar characteristics, e.g., accounts receivable No No action
Step 2: Are there indications that the asset or group of similar assets is impaired? Yes Step 3: Has there been a signicant adverse change during the period in the expected timing or amount of future cash ows from the asset(s)? Yes Step 4: Is carrying amount higher than highest of: Present value of cash ows expected to be generated by holding the asset(s) Expected net proceeds from selling the asset(s) at the balance sheet date Expected net value of collateral held Yes Action: Reduce carrying amount to highest of three amounts In subsequent periods Step 5: Has the situation identied in Step 2 improved? Yes Step 6: Is the carrying amount lower than the highest of: Present value of cash ows expected to be generated by holding the asset(s) Expected net proceeds from selling the asset(s) at the balance sheet date Expected net value of collateral held Yes Action: Increase carrying amount to lower of: the amount calculated in Step 6; and the carrying amount that would have been recorded had the asset not been previously impaired
No
No action
No action No
No
No action
No action No
18
Financial Instruments
50.
Example Impairment assessment Investor Corporation holds a portfolio of debt and equity securities amounting to $25,000. This portfolio is comprised of $15,000 of investments in equity securities of three private companies, and $10,000 in debt securities. Investor Corp. has determined the following for its impairment review: Equity instruments to be reviewed individually: $5,000 investment in preferred shares of Company A $3,000 investment in common shares of Company B $7,000 investment in special shares of Company C Debt securities to be reviewed individually due to their signicance: $6,000 investment in bonds of Company D Debt securities to be reviewed individually due to their shared industry characteristic: $3,000 aggregate investment in bonds of various companies in the utilities sector The remaining $1,000 are individually insignicant and would be reviewed only when information comes to the attention of Investors management.
51.
A nancial asset is impaired when the holder expects a signicant adverse change in either the amount or timing of future cash ows. For an investment in an equity instrument, the most signicant potential decrease in future cash ows arises from the inability to sell the shares at a price that recovers the initial investment. Uncertainty about an entitys future cashgenerating ability generally results in a decline in the fair value of the entity. Indications that the investment might be at risk include: (a) It becomes probable that the issuer will enter bankruptcy or other nancial reorganization; (b) The issuer experiences a signicant adverse change in the technological, market, economic or legal environment in which it operates. The effect of possible changes in the industry in which the issuer operates needs to be assessed. This includes changes in: (i) the technology used to produce the entitys product; (ii) the competitive environment in which it operates, including changes in the way the product is distributed that increase the number of suppliers with reasonable access to the entitys customers; (iii) national or local economic conditions; (iv) environmental sensitivities or laws; or (v) tax laws.
52.
Accounts receivable are similar in nature to interest-bearing assets such as loans, bankers acceptances, guaranteed investment certicates, term notes and bonds. Although the same process for recognizing and measuring impairment applies to accounts receivable as to other nancial assets, the model should not result in a change in process from existing practice. Indications that an interest-bearing asset is impaired include: (a) The customer or issuer appears to be experiencing signicant nancial difculty. This may be evident by: (i) late payments or defaults in either the instrument held by the creditor or investor or in debts owed to other creditors or investors;
(ii) a breach of a non-nancial contract; or (iii) concessions granted to the customer. (b) It becomes probable that the customer or issuer will enter bankruptcy or other nancial reorganization. (c) The market for nancial instruments issued by the obligor disappears. (d) Liquidity for the type of instrument decreases due to a lack of popularity for that type of investment. (e) A signicant adverse change in the technological, market, economic or legal environment in which the customer or issuer operates (see paragraph 51 above). 53. The following events or circumstances do not necessarily indicate impairment: (a) An active market disappears because an entitys nancial instruments are no longer publicly traded. (b) The issuers credit rating is downgraded. However, any downgrade should be evaluated to determine whether the amounts or timing of cash ows from the nancial instrument held are at risk of signicant change.
19 The Canadian Institute of Chartered Accountants
Financial Instruments
(c) A decrease in the fair value of a nancial asset below its cost or amortized cost may be due to changes in the risk-free interest rate or other exogenous factors. 54. Section 3856 does not dene signicant; judgment is required. The assessment should consider the cash ows that are expected to be derived over the period of time that the entity expects to hold the nancial asset, including any applicable proceeds of disposal. Examples of situations that might be considered a signicant adverse change include a change in expectation of collection of a receivable from 60 days to 180 days or receiving notice that a past due receivable will be settled for $0.80 on the dollar. Example Indications of impairment Lendor Corporation has lent one of its customers, Big Box Incorporated (Big Box), $10,000 on February 14, 20X1. By December 31, 20X1, it is clear that customer trends have changed and one of Big Boxs competitors has introduced a new product to the market that is really taking off, leaving Big Boxs product out of date and not nearly as popular as it once was. Big Box has also approached Lendor Corporation to renegotiate and extend its repayment terms because it has been having difculty with its cash ow considering recent events. Lendor Corp. should consider the fact that Big Box has asked to extend its repayment terms as well as the downturn in Big Boxs economic situation to be indications of a signicant adverse change in the expected timing or amount of future cash ows associated with its loan receivable.
Measurement of impairment
55.
56.
When a signicant adverse change in future cash ows from the asset is expected, any impairment loss is calculated in accordance with paragraph 3856.17. The write-down, if any, is to the highest of three possible amounts: (a) The present value of the cash ows expected to be generated by holding the asset(s), discounted using a current market rate of interest appropriate to the asset(s); (b) The amount that could be realized by selling the asset(s) at the balance sheet date; and (c) The amount expected to be realized by exercising rights to collateral held to secure the repayment of the asset(s), net of all costs necessary to exercise the rights.
57.
Section 3856 assumes the holder of the asset will take whatever action is necessary to maximize cash ows from impaired nancial assets. However, it does not presume a course of action. This means that the reporting entity may manage an asset in a different manner from that corresponding to the measurement. For example, collateral backing an asset may be worth more than either the present value of the assets future cash ows or the amount that could be realized on sale of the asset. The value of the collateral would be used even if the reporting entity does not intend foreclosing on the asset and realizing the collateral. Even though, conceptually, the net realizable amount from a hypothetical sale of the asset should be equal to the higher of the net realizable value of the collateral and the net present value of the future cash ows, Section 3856 does not presume that markets for these assets are liquid or perfect. The interest rate to be used to discount future cash ows is determined based on judgment. The rate should reect the type of asset under consideration. For example, a loan should be remeasured using the rate that would be charged for a loan with comparable term, conditions and quality at the balance sheet date. Cash ows from other interest-bearing assets should be discounted using current yields for the asset, if observable, or a comparable asset. If the reporting entity has granted concessions to a borrower by reducing the interest rate below the current market rate, the amount of the loss reported will include a component for foregone interest. This is illustrated in the example in paragraph 60.
58.
59.
20
Financial Instruments
60.
Example Present value of future cash ows of a loan Richco extended a $120,000, three-year loan to Sadco in 20X0. Sadco is required to pay interest only at 10% with principal due in full June 30, 20X3. Sadco lost its most signicant customer to bankruptcy shortly after the loan was extended. Sadco made all required payments in 20X0. In January 20X1, Sadco asked for a reduction in the interest rate to 5% and an extension in the nal payment to June 30, 20X4. The loan is not collateralized. Depending on market rates of interest, the impairment loss Richco calculates is: Market interest rate 5% 10% 12% Present value of renegotiated cash ows $121,040 $103,703 $104,330 Carrying amount of loan 120,000 120,000 120,000 Impairment loss recognized $ 0 $ 11,297 $ 15,670 The impairment loss The impairment loss represents the difference represents the difference between the new interest between the new interest rate and the market rate. rate and the market rate. If the term of the loan had not been extended, the loss would have been $9,917. Subsequent to recognizing the write-down, Richco recognizes interest at 5%. If Sadco rebuilds its customer base, all or part of the loss might be reversed. (See paragraph 66 below.) Because the loan has been renegotiated to a market rate of interest, no impairment loss is recognized.
61.
Impairment losses realized on unquoted equity instruments or derivative assets that are linked to, and must be settled by delivery of, unquoted equity instruments are more difcult to measure than interest-bearing investments. Estimates of the fair value of the shares and cash ows that might reasonably be expected over the anticipated hold period are required. Future cash ows might be discounted using the required yield for an investment with comparable terms and risk or possibly using an estimate of the entitys weighted average cost of capital. It is not always necessary to perform the three calculations in paragraph 3856.17. The best estimate of a selling price for an asset may be equivalent to the present value of its cash ows and there may be no collateral backing the asset. Estimates of the amount and timing of expected future cash ows from impaired nancial assets should reect managements best judgment, based on reasonable and supportable assumptions, taking into account the range of possible outcomes. Although making reliable estimates of the amounts and timing of expected future cash ows from a group of assets is constrained by limitations on the availability of information as well as the inability to assess the effect on individual accounts, there is a presumption that reasonable assumptions can still be made.
62. 63.
21
Financial Instruments
64.
Example Cash ow estimates (continued from paragraph 55 above) Lendor Corporations loan to Big Box Incorporated has a carrying amount of $100,000 on December 31, 20X1. After much discussion with Big Boxs management, Lendor Corp. has agreed to extend the repayment period to mature February 14, 20X6 instead of the original maturity date of February 14, 20X4. Assume that the loan is priced at 3.25%, paid monthly and that a current market rate of interest appropriate to Big Box is 4.5%. Probability weighted Probability Outcome gross cash ows Present value 5% No payments $ 0 $ 0 5% $30,000 principal plus interest until Feb. 20X4 1,852 1,572 10% $50,000 and interest until Feb. 20X5 6,029 5,097 20% $70,000 and all interest 16,708 14,079 60% $100,000 principal and all interest 68,125 57,220 $92,714 $77,968 The amount that Big Box expects to realize by exercising its right to collateral net of all costs necessary to exercise those rights is $70,000. Lendor Corp. records an impairment in the amount of $22,032 through net income at December 31, 20X1 as follows: Dr. Credit loss $22,032 Cr. Loan receivable (or allowance for loan loss) $22,032 By December 31, 20X2, the present value of the cash ows expected to be generated by holding the loan is estimated at $78,700, while the amount expected to be realized by exercising their rights to collateral (net of all costs necessary to exercise those rights) is $72,000. However, Lendor does not record the increase because there is no indication that the conditions that caused it to evaluate the loan for impairment have improved (see paragraph 66 below).
Impairment of groups of assets
65.
When history suggests that bad debt losses will be experienced on some assets in a group but it is not yet apparent which assets will default, an allowance for impairment is calculated, e.g., an allowance for doubtful accounts receivable. When information becomes available about the impairment of specic assets in the group, those assets are removed from the group and assessed for impairment on an individual basis.
Reversals
66.
At each reporting date all assets previously identied as impaired are reviewed to determine whether all or part of the impairment loss should be reversed. When an increase in value of the asset can be related to an improvement in the condition(s) that caused the loss, a gain is recognized. The carrying amount of the asset may not be increased above the amount that would have been reported at the reporting date had an impairment loss not been previously recorded. (Refer to paragraph 49 above, steps 5 and 6.) The amount of the reversal is recognized in net income in the period the reversal occurs. Examples of circumstances that might indicate that an impairment reversal may be possible include: (a) The customer or issuer previously experiencing signicant nancial difculty seems to be doing better. This may be evident by faster payments, the absence or cure of events of default, or a commitment to resume interest or principal payments. (b) Renegotiation of a contract to incorporate commercial terms appropriate to a party free from liquidity, solvency, or profitability concerns, or reinstatement of dividend payments. (c) Emergence from receivership or bankruptcy protection. (d) An improvement in the technological, market, economic or legal environment in which the customer or issuer operates. A recovery in the fair value of an investment in an equity instrument above its cost might be indicative of improvement, but the reporting entity should consider whether the improvement is specic to the issuer and sustainable through its intended holding period. Other indicators might include: (i) Increased popularity of the issuer or customers product (ii) Structural changes in the customer or issuers industry such as new technology or a change in the number of competitors (iii) Changes in external variables such as environmental or tax laws.
22
67.
Financial Instruments
68.
Example Impairment reversal (continued from paragraph 64 above) By December 31, 20X2, it is clear that the new product introduced by Big Boxs competitor is faulty and receives signicant negative exposure in the media. As a result, the market now has renewed interest in Big Boxs products noting their stable reputation for high quality and reliability. Big Boxs management recently contacted Lendor Corp. to conrm their intention to repay the loan in full over the next ve years. Lendor is cautiously optimistic and revises its estimate of expected cash ows as follows: Probability Probability Outcome weighted outcome Present value 0% No further payments $ 0 $ 0 5% $40,000 principal and all interest 2,515 2,207 5% $60,000 principal and all interest 3,515 3,077 10% $80,000 principal and all interest 9,029 7,894 80% $100,000 principal and all interest 88,233 77,074 $103,292 $90,253 The value of the collateral has increased to $75,000. Lendor increases the carrying amount of the loan to Big Box from $77,968 to $90,253 and records the following entry: Dr. Loan receivable (or allowance for loan losses) $12,285 Cr. Credit loss $12,285
Fair value
69.
Fair value is dened in paragraph 3856.05(f) as follows: Paragraph 3856.05(f) Fair value is the amount of the consideration that would be agreed upon in an arms length transaction between knowledgeable, willing parties who are under no compulsion to act. (Paragraph 3856.A7 provides related application guidance.)
70.
In practice, this denition can be difcult to apply. As such, there are a few things to keep in mind when trying to determine fair value for a particular instrument: (a) Fair value measurement presumes the going concern assumption applies. This means that fair value is not an amount an entity would pay in a forced transaction, involuntary liquidation or distressed sale. (b) Fair value reects the credit quality of the instrument, including any collateral or other credit enhancements. (c) Quoted prices in an active market are the best evidence of fair value so long as they reect actual and regularly occurring market transactions on an arms length basis, which will be the case when prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service or regulatory agency. (d) When current rates or prices are unavailable, the price of the most recent transaction may provide evidence of the current fair value considering whether there have been any signicant changes in the economic circumstances since the time that the most recent transaction took place. (e) In the absence of a recent transaction for the instrument that is being measured, fair value may be based on a recent price for a similar proxy instrument. (f) In some cases, it may be prudent to consider engaging the use of a specialist or valuator in determining fair value.
23
Financial Instruments
71.
Example Fair value sources by instrument Instrument Equity instrument quoted in an active market Non-option derivatives Fair value or proxy Latest closing price Mid-market prices or rates consistent with prices that would be supplied by banks Quote from a derivatives dealer Bid prices for purchased options and ask prices for issued options (mid-market prices may be used) Quote from a derivatives dealer Software packages Present value of all future cash receipts discounted using the prevailing market rates of interest for a similar instrument (as to currency, term, type of interest rate, or other relevant factors) with a similar credit rating
Option derivatives
72.
Example Calculating the change in fair value of a forward contract ABC Corporation (ABC), purchases a forward contract (a derivative) on January 15, 20X1 to purchase $100,000 USD on August 1, 20X1 at a rate of 1.045. ABC will receive $100,000 USD in exchange for $104,500 CAD on August 1, 20X1. The spot rate on January 15, 20X1 was 1.05. On March 31, 20X1. ABCs year-end, the forward rates for US dollars, as published in the local newspaper or reputable website, are as follows: 1-Month 2-Months 3-Months 4-Months 5-Months 6-Months Forward rate 1.049 1.048 1.046 1.047 1.046 1.045 The change in the fair value of the foreign currency forward contract at March 31, 20X1 is calculated as follows: f(t) = (F(t) K)e rf(T t) dened as follows: f(t) = forward contract value at time t F(t) = forward exchange rate at time t K = price per contract at inception rf = Canadian risk free interest rate T-t = duration of the contract in years. When the effect of time value is not material, the change in the intrinsic value of the contract may be used as a proxy for the change in its fair value. The effect of time value is small when the interest rates are low, when the contract is of short duration or when the change in the intrinsic value of the forward contract is not material. The change in intrinsic value is calculated as follows: Foreign currency forward contract x (contract rate contract rate in effect at the period-ended) Using the example above, the change in fair value of the foreign currency forward contract is estimated as follows: $100,000 * (1.047 forward rate in 4 months time 1.045 contracted rate) = $200. The Company would record the following entry to record the change in fair value of the forward contract: Dr. Derivative asset $200 Cr. Unrealised gain on derivative (net income) $200 Alternatively, the providing nancial institution might provide an estimated fair value for the forward contract.
24
Financial Instruments
73.
Example Calculating the change in fair value of an interest-rate swap On January 1, 20X1, Coverage Corporation borrowed $5,000,000 repayable in ve years at prime plus 1.5%. On June 1, 20X1, Coverage Corporation decides to enter into an interest rate swap to minimize its exposure to uctuations in the prime rate. Under the swaps terms, Bank of Lenders pays Coverage Corporation prime plus 1.5% and Coverage pays Bank of Lenders 3.5% xed for the remaining term of the loan. If Coverage Corporation does not want to apply hedge accounting, Coverage Corporation is required to measure the swap at fair value at each reporting period. The fair value of the swap can be estimated with the use of commercially available software and prices or by requesting an approximate fair value of the swap from Bank of Lenders. To verify whether the estimate received from the bank is reasonable, the following technique can be used: Notional amount $5,000,000 Number of months remaining in swap agreement 54 months Prime Rate Current 1.30% Expected average High end of range 3.80% Expected average Low end of range 3.30% Interest rate of the debt Variable 2.80% Interest rate of the swap Fixed 3.50% Discount rate risk-free rate based on remaining term swap 2.00% Discounted cash ows High/Low estimate High Fixed rate $5,000,000 x 3.50% = $(175,000) Variable $5,000,000 x 3.80% = $190,000 Difference per year $15,000 Difference per month $ 1,250 Present value of future cash ows $64,500 Low Fixed rate $5,000,000 x 3.50% = $(175,000) Variable $5,000,000 x 3.30% = $165,000 Difference per year $(10,000) Difference per month $ (833) Present value of future cash ows $(43,000) External valuation Mark-to-market from bank $ 52,000 Conclusion: Because the banks valuation is within the high/low range, the value provided by the bank is reasonable. Note: If the swap value is material to the overall nancial statements, a more precise technique should be considered to estimate the reliability of the banks estimate, such as determining points along the interest rate curve over the remaining term of the swap.
Indexed nancial liabilities
74.
Section 3856 requires that the readers of an entitys nancial statements are alerted to any terms of a liability that might cause unusual future cash ows. When a liability is indexed to a measure of the entitys performance, it must be measured using an estimate of the intrinsic value of the indexing feature at the reporting date. Examples of indexing features are payments that are based on actual or average net income or earnings before interest, taxes, depreciation and amortization (EBITDA), the increase in net income or EBITDA above a specied baseline and the increase in share price or value above a specied baseline. Any amount recognized at a reporting date as an additional amount payable is reported as a separate component of interest expense. If at a subsequent reporting date the additional payment would not be required, the carrying amount of the liability is revised and the adjustment is recognized as a deduction from interest expense. In applying a formula that ultimately measures the payment based on performance over a number of periods, some of which have yet to occur, the formula is applied as if the formula applies only to periods ending with the reporting date.
25 The Canadian Institute of Chartered Accountants
75.
Financial Instruments
76.
Example Indexed nancial liability On July 1, 20X1, Private Corporation issues a $100,000 ve-year note bearing interest at 8% plus 10% of the average earnings before interest, taxes, depreciation and amortization (EBITDA) for the ve years ending June 30, 20X6. The note is measured as follows: Date Entries required Reported balances July 1, 20X1 Dr. Cash $100,000 Note payable $100,000 Cr. Notes payable $100,000 June 30, 20X2 Dr. Interest expense $13,300 EBITDA $ 53,000 Cr. Cash $8,000 Note payable 105,300 Cr. Note payable 5,300 (10% x $53,000) June 30, 20X3 Dr. Interest expense $2,700 EBITDA(loss) $(65,000) Dr. Note payable 5,300 Note payable 100,000 Cr. Cash $8,000 June 30, 20X4 Dr. Interest expense $9,200 EBITDA $48,000 Cr. Cash $8,000 Note payable 101,200 Cr. Note payable $1,200 (10% x (53,000 65,000 + 48,000)/3) June 30, 20X5 Dr. Interest expense $9,800 EBITDA $84,000 Cr. Cash $8,000 Note payable 103,000 Cr. Note payable 1,800 (10% x (53,000 65,000 + 48,000 + 84,000)/4) 1,200 June 30, 20X6 Dr. Interest expense $9,500 EBITDA $105,000 Cr. Cash $8,000 Note payable 104,500 Cr. Note payable 1,500 (10% x (53,000 65,000 + 48,000 + 84,000 + 105,000)/5) 3,000 PRESENTATION Offsetting
77.
Offsetting refers to the presentation of a recognized nancial asset and a recognized nancial liability as a single net asset or liability on the face of the balance sheet. Neither instrument is actually derecognized. (See paragraph 86 below for discussion of derecognition.) Offsetting differs from derecognition in the following ways: (a) No gain or loss is recognized. (b) Unlike a transfer of assets that results in sale treatment because the entity surrenders control (a derecognition transaction), nancial assets that are offset by nancial liabilities continue to be controlled by their owner. (c) Unlike an extinguishment of debt, where the debtor is legally released from its obligation (a derecognition transaction), the debtor remains obligated to repay the debt that is offset against one or more assets.
78.
79.
The determination of whether nancial assets should be offset with nancial liabilities is important because gross or net presentation can have a signicant impact on the following key ratios (among others) that are sometimes used to measure liquidity and protability: (a) Current ratio (b) Return on assets (c) Debt to equity or other leverage measures.
80.
From a risk perspective, entering into contracts with the legally enforceable right of offset may help manage an entitys exposure to credit and settlement risk with counterparties. The two conditions that must be present in order to offset are: (a) An entity has a legally enforceable right to set off the recognized amounts; and (b) An entity intends either to settle on a net basis, or to realize the asset and settle the liability simultaneously.
26
Financial Instruments
Legal right of offset
81.
A legally enforceable right of offset is a function of both the facts and circumstances of the transaction and its governing laws and regulations. In some cases, laws or regulations, or the operation of common law may contradict rights otherwise provided by contract. A right of offset that is legally enforceable only in the event of the default of one of the parties to the contract does not satisfy the requirement that the right of set-off be currently enforceable. Further, such a contract does not meet the intent requirement of the standard.
Intent to settle net
82.
83.
The intention condition is necessary to faithfully represent the entitys expected sources and uses of cash. Intent to settle net must be documented or supported by the entitys history of set-off in similar situations. In the absence of an explicit settlement mechanism and date, an entity cannot assert that it intends to net settle two or more transactions. Interest, dividends, losses and gains
84.
The presentation of any interest, dividends, losses and gains relating to nancial instruments in either income (or expenses) or equity will be dictated by the classication of the nancial instrument on the balance sheet. Distributions to holders of a nancial liability are presented in net income as expense, e.g., interest. Distributions on equity instruments are presented directly in equity, e.g., dividends. Similarly, gains and losses associated with redemptions or renancings of instruments classied as liabilities are reported in net income, and redemptions or renancings of instruments classied as equity are reported as changes in equity. Amortization of nancing fees and transaction costs, debt premiums or discounts may be presented as a separate component of interest income or expense. DERECOGNITION Financial assets
85.
86.
Derecognition refers to the process of removing a previously recognized nancial asset or nancial liability from an entitys balance sheet. Section 3856 provides guidance on securitization of receivables formerly in ACCOUNTING GUIDELINE AcG 12, Transfers of Receivables, and derecognition of nancial liabilities. The focus of the guidance on transfers of assets focuses on transactions that result in the transferor retaining some continuing interest in the transferred assets.
Securitization transactions
87.
Receivables such as mortgage loans, automobile loans, trade receivables, credit card receivables, and other revolving charge accounts are assets commonly transferred in securitizations. Securitizations of mortgage loans may include pools of singlefamily residential mortgages or other types of real estate mortgage loans (for example, multi-family residential mortgages and commercial property mortgages). Securitizations of loans secured by chattel mortgages on automotive vehicles as well as other equipment (including direct nancing or sales-type leases) are also common. Both nancial and non-nancial assets can be securitized. Life insurance policy loans, patent and copyright royalties, and even taxi medallions have been securitized but securitizations of non-nancial assets are outside the scope of Section 3856. An originator of a typical securitization (the transferor) transfers a portfolio of receivables to a special purpose entity (SPE), commonly a trust or co-ownership pool. In certain pass-through and pay-through securitizations, receivables are transferred to the SPE at the inception of the securitization, and no further transfers are made; all cash collections are paid to the holders of benecial interests in the SPE. In certain revolving-period securitizations, receivables are transferred at the inception and also periodically (daily or monthly) thereafter for a dened period (commonly three to eight years), referred to as the revolving period. During the revolving period, the SPE uses most of the cash collections to purchase additional receivables from the transferor on prearranged terms. In these structures, benecial interests in the SPE are sold to investors and the proceeds are used to pay the transferor for the assets transferred. Those benecial interests may comprise either a single class having equity characteristics or multiple classes of interests, some having debt characteristics and others having equity characteristics. The cash collected from the portfolio is distributed to the investors and others as specied by the legal documents that established the SPE. Pass-through, pay-through, and revolving-period securitizations that meet the criteria in paragraph 3856.B5 qualify for sale accounting. All nancial assets obtained or retained and liabilities incurred by the originator of a securitization that qualies as a sale are recognized and measured as provided in paragraph 3856.B39. This includes the implicit forward contract to sell
27 The Canadian Institute of Chartered Accountants
88.
89.
90.
Financial Instruments
new receivables during a revolving period, which may become valuable or onerous to the transferor as interest rates and other market conditions change. 91. Illustration Typical securitization transaction